InMed Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
IMLFF InMed Pharmaceuticals Inc
TRSSX T. Rowe Price Institutional Small-Cap Stock Fund
SSSS SuRo Capital Corp
AVD American Vanguard Corp
VMVFX Vanguard Global Minimum Volatility Fund Investor Shares
IO ION Geophysical Corp
DNRCQ Denbury Resources Inc
MSFT Microsoft Corp
BCRX BioCryst Pharmaceuticals Inc
WMT WALMART STORES INC
Go

Health Care : Biotechnology | Small Cap Growth
Based in Canada
Company profile

InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company. The Company specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis based-therapies. The Company is working on two products, which include INM-750, for the treatment of Epidermolysis Bullosa (EB), and INM-085, for the treatment of Glaucoma. The INM-750 is a therapy developed for EB designed specifically to modulate disease activity and to alleviate symptoms. The INM-085 is designed as a dual-action cannabinoid ocular therapy. INM-085 is designed as a topical formulation to be administered directly to the eye. It is working on the development of several cannabinoid-based treatments for multiple diseases, including ocular, dermatology, cancer, inflammation, pain and arthritis disease areas. Its subsidiary is Biogen Sciences Inc. (BSI).

Price
Delayed
$5.24
Day's Change
0.0757 (1.47%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.37
Day's Low
5.20
Volume
(Heavy Day)

Today's volume of 3,098 shares is on pace to be much greater than IMLFF's 10-day average volume of 13,654 shares.

3,098
  • Prev Close
    5.16
  • Today's Open
    5.33
  • Day's Range
    5.20-5.37
  • Avg Vol (10-day)
    13.7K
  • Last (time)
    9:59a ET 08/14/20
  • Last (size)
    7
  • 52-Wk Range
    3.40 - 11.09
    LowHigh
  • (09/10/19 - 07/27/20)
    53.97%
  • 101.2%
  • Market Cap
    27.5M
  • Shares Outstanding
    5.2M
  • -2.65
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.6
  • 0.09
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.